Ocular Therapeutix, Inc. (OCUL)

7.78 +0.75 (+10.67%) USD  |  NASDAQ  |  Feb 20, 16:00
8.02 +0.24 (+3.08%) After-Hours: 06:28
More

Ocular Therapeutix Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
EyePoint Plc Upgrade
Vertex Pharmaceuticals, Inc. Upgrade